Preoperative Nomograms and Artificial Neural Networks (ANNs) for Identification of Surgical Candidates
暂无分享,去创建一个
[1] M. Kattan,et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. , 1998, Human pathology.
[2] M W Kattan,et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Partin,et al. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma , 2001, Cancer.
[4] M W Kattan,et al. A catalog of prostate cancer nomograms. , 2001, The Journal of urology.
[5] A W Partin,et al. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. , 2000, Urology.
[6] A. Zlotta,et al. 129 PSA molecular forms and indices for early detection of prostate cancer in men with total PSA between 2.0 and 4.0 ng/ml: final results of the EPCD study , 2004 .
[7] J. Blasko,et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. , 2001, Urology.
[8] W. Catalona,et al. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. , 1994, The Journal of urology.
[9] D. E. Neal,et al. Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study. , 1998, British Journal of Cancer.
[10] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[11] Pierre I Karakiewicz,et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Mesut Remzi,et al. An artificial neural network to predict the outcome of repeat prostate biopsies. , 2003, Urology.
[13] R W Veltri,et al. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. , 1999, Urology.
[14] A W Partin,et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. , 2000, The Journal of urology.
[15] Hartwig Huland,et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.
[16] E J Gamito,et al. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. , 2001, Molecular urology.
[17] Mesut Remzi,et al. Artificial neural networks for decision-making in urologic oncology. , 2003, Reviews in urology.
[18] Mesut Remzi,et al. Novel artificial neural network for early detection of prostate cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] P. Kantoff,et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] Mesut Remzi,et al. PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. , 2003, European urology.
[21] A W Partin,et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.
[22] J. Bishoff,et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms. , 2003, Urology.
[23] Mesut Remzi,et al. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. , 2003, The Journal of urology.
[24] M. Kattan,et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. , 2004, The Journal of urology.
[25] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[26] Kevin Regan,et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[28] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[29] A W Partin,et al. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. , 2001, Urology.
[30] Michael W. Kattan,et al. Expert Systems in Medicine , 2001 .
[31] E. Crawford,et al. Impact of different variables on the outcome of patients with clinically confined prostate carcinoma: prediction of pathologic stage and biochemical failure using an artificial neural network. , 2001, Cancer.
[32] Mesut Remzi,et al. Artificial Neural Networks in Urology 2004 , 2004 .
[33] Victor Reuter,et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. , 2003, The Journal of urology.
[34] Thomas M. Wheeler,et al. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .
[35] M. Brawer,et al. Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint® scintiscans , 2000, The Prostate.
[36] U Pichlmeier,et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. , 2001, The Journal of urology.
[37] Michael W Kattan,et al. Prediction of progression: nomograms of clinical utility. , 2002, Clinical prostate cancer.
[38] E D Crawford,et al. Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy. , 2000, Techniques in urology.
[39] Michael W Kattan,et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. , 2003, The Journal of urology.